APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $844 | -56.8% | 22,185 | +3.6% | 0.01% | -56.2% |
| Q2 2023 | $1,952 | +122.6% | 21,422 | +61.1% | 0.02% | +128.6% |
| Q1 2023 | $877 | +10.2% | 13,294 | -13.7% | 0.01% | 0.0% |
| Q4 2022 | $796 | -99.9% | 15,403 | +1.5% | 0.01% | -30.0% |
| Q3 2022 | $1,036,000 | +59.1% | 15,172 | +5.4% | 0.01% | +66.7% |
| Q2 2022 | $651,000 | +2.8% | 14,400 | +15.5% | 0.01% | +20.0% |
| Q1 2022 | $633,000 | -46.6% | 12,464 | -50.3% | 0.01% | +25.0% |
| Q4 2021 | $1,186,000 | +211.3% | 25,102 | +117.3% | 0.00% | +33.3% |
| Q3 2021 | $381,000 | -50.8% | 11,554 | -5.8% | 0.00% | -50.0% |
| Q2 2021 | $775,000 | +111.2% | 12,265 | +43.5% | 0.01% | -57.1% |
| Q1 2021 | $367,000 | -31.7% | 8,550 | -8.9% | 0.01% | -30.0% |
| Q4 2020 | $537,000 | +90.4% | 9,383 | +0.5% | 0.02% | +66.7% |
| Q3 2020 | $282,000 | -10.2% | 9,332 | -2.9% | 0.01% | -20.0% |
| Q2 2020 | $314,000 | +23.6% | 9,614 | +1.3% | 0.02% | +150.0% |
| Q1 2020 | $254,000 | -5.2% | 9,487 | +8.6% | 0.01% | +20.0% |
| Q4 2019 | $268,000 | +29.5% | 8,739 | +1.9% | 0.01% | +25.0% |
| Q3 2019 | $207,000 | -5.5% | 8,577 | -0.9% | 0.00% | -20.0% |
| Q2 2019 | $219,000 | – | 8,657 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |